ArticleFrontiers in microbiology2021
Molecular Epidemiology and Antimicrobial Resistance of
Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 24 citations in OpenAlex.
- The emergence and biological characteristics of linezolid-resistantEmerging microbes & infections · 2026Article
- Characterization of resistance to last-line therapeutic molecules and genetic diversity ofJournal of medical microbiology · 2026Article
- Comparative genomic analysis of Clostridioides difficile strains in Mexico: insights into virulence and resistance.Access microbiology · 2026Article
- Molecular epidemiology and antimicrobial resistance profiles ofFrontiers in microbiology · 2026Article
- Antibiotic resistance patterns, toxin profiles, and toxin gene expression levels among Clostridioides difficile PCR ribotypes isolated from patients scheduled for colonoscopy.Molecular biology reports · 2025Article
- Mechanisms of fusidic acid resistance.Biochemical Society transactions · 2025Review
- The Central Importance of Vaccines to Mitigate the Threat of Antibiotic-Resistant Bacterial Pathogens.Vaccines · 2025Review
- Comparison of virulence and resistance genes inMicrobiology spectrum · 2025Article
- Genomic Characterization of Linezolid-ResistantBiotech (Basel (Switzerland)) · 2025Article
- Characterization of High-Linezolid-MICInfection and drug resistance · 2025Article
- Clinical characteristics and risk factors ofFrontiers in pediatrics · 2025Article
- Genomic and phenotypic studies amongMicrobiology spectrum · 2024Article
- Toxin genotypes, antibiotic resistance and their correlations in Clostridioides difficile isolated from hospitals in Xi'an, China.BMC microbiology · 2024Article
- Antimicrobial Resistance Genes in Respiratory Bacteria from Weaned Dairy Heifers.Pathogens (Basel, Switzerland) · 2024Article
- Whole genome sequence analysis reveals high genomic diversity and potential host-driven adaptations among multidrug-resistantFrontiers in microbiology · 2024Article
- Antibiotic Resistances of Clostridioides difficile.Advances in experimental medicine and biology · 2024Article
- Genomic Characterization of Three NovelMicroorganisms · 2023Article
- Detection and Genomic Characterisation ofPathogens (Basel, Switzerland) · 2022Article
- Preventive and therapeutic effect ofFrontiers in nutrition · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.